Targeting Forward and Reverse EphB4/EFNB2 Signaling by a Peptide with Dual Functions
2020 · Scientific Reports · 13 citations
https://doi.org/10.1038/s41598-020-57477-x
A
Anca Chelariu-Raicu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
141
Papers
784
Citations
16
h-index
28
i10-index
Anca Chelariu-Raicu is an academic researcher. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & PARP inhibition in cancer therapy & MicroRNA in disease regulation. The author has an h-index of 16, co-authored 120 publications.
ORCID: 0000-0003-2944-9488Papers by this author
worksEndothelial p130cas confers resistance to anti-angiogenesis therapy
2022 · Cell Reports · 8 citations
https://doi.org/10.1016/j.celrep.2022.110301
Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer
2022 · Journal of Cancer Research and Clinical Oncology · 5 citations
https://doi.org/10.1007/s00432-022-04114-x
Endothelial p130cas confers resistance to anti-angiogenesis therapy
2022 · Cell Reports · 4 citations
https://doi.org/10.1016/j.celrep.2022.110999
IMGN853 Induces Autophagic Cell Death in Combination Therapy for Ovarian Cancer
2025 · Cancer Research Communications · 3 citations
https://doi.org/10.1158/2767-9764.crc-24-0215
Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer
2023 · Journal of Cancer Research and Clinical Oncology · 1 citations
https://doi.org/10.1007/s00432-023-04708-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat